WWP2-WWP1 Ubiquitin Ligase Complex Coordinated by PPM1G Maintains the Balance between Cellular p73 and ΔNp73 Levels

被引:35
作者
Chaudhary, Neelam [1 ]
Maddika, Subbareddy [1 ]
机构
[1] Ctr DNA Fingerprinting & Diagnost, Lab Cell Death & Cell Survival, Hyderabad, Andhra Pradesh, India
基金
英国惠康基金;
关键词
DECREASED EXPRESSION; BREAST CANCERS; DNA-DAMAGE; E3; LIGASE; PROTEIN; P53; GENE; TAP73; WWP2; APOPTOSIS;
D O I
10.1128/MCB.00101-14
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The balance between transcription factor p73 and its functionally opposing N-terminally truncated Delta Np73 isoform is critical for cell survival, but the precise mechanism that regulates their levels is not clear. In our study, we identified WWP2, an E3 ligase, as a novel p73-associated protein that ubiquitinates and degrades p73. In contrast, WWP2 heterodimerizes with another E3 ligase, WWP1, which specifically ubiquitinates and degrades Delta Np73. Further, we identified phosphatase PPM1G as a functional switch that controls the balance between monomeric WWP2 and a WWP2/WWP1 heterodimeric state in the cell. During cellular stress, WWP2 is inactivated, leading to upregulation of p73, whereas WWP2-WWP1 complex is intact to degrade Delta Np73, thus playing an important role in shifting the balance between p73 and Delta Np73. Collectively, our results reveal a new functional E3 ligase complex controlled by PPM1G that differentially regulates cellular p73 and Delta Np73.
引用
收藏
页码:3754 / 3764
页数:11
相关论文
共 36 条
[1]
Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers:: Prevalence of alterations in inflammatory breast cancers [J].
Ahomadegbe, JC ;
Tourpin, S ;
Kaghad, M ;
Zelek, L ;
Vayssade, M ;
Mathieu, MC ;
Rochard, F ;
Spielmann, M ;
Tursz, T ;
Caput, D ;
Riou, G ;
Bénard, J .
ONCOGENE, 2000, 19 (47) :5413-5418
[2]
P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism [J].
Al-Bahlani, S. ;
Fraser, M. ;
Wong, A. Y. C. ;
Sayan, B. S. ;
Bergeron, R. ;
Melino, G. ;
Tsang, B. K. .
ONCOGENE, 2011, 30 (41) :4219-4230
[3]
Araki D, 2002, INT J ONCOL, V20, P355
[4]
Structure and function in the p53 family [J].
Arrowsmith, CH .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (12) :1169-1173
[5]
WWP2 ubiquitin ligase and its isoforms New biological insight and promising disease targets [J].
Chantry, Andrew .
CELL CYCLE, 2011, 10 (15) :2437-2439
[6]
The Nedd4-like family of E3 ubiquitin ligases and cancer [J].
Chen, Ceshi ;
Matesic, Lydia E. .
CANCER AND METASTASIS REVIEWS, 2007, 26 (3-4) :587-604
[7]
p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas [J].
El-Naggar, AK ;
Lai, SL ;
Clayman, GL ;
Mims, B ;
Lippman, SM ;
Coombes, M ;
Luna, MA ;
Lozano, G .
CARCINOGENESIS, 2001, 22 (05) :729-735
[8]
Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53 [J].
Grob, TJ ;
Novak, U ;
Maisse, C ;
Barcaroli, D ;
Lüthi, AU ;
Pirnia, F ;
Hügli, B ;
Graber, HU ;
De Laurenzi, V ;
Fey, MF ;
Melino, G ;
Tobler, A .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (12) :1213-1223
[9]
Regulation of the p53 pathway by ubiquitin and related proteins [J].
Hock, Andreas ;
Vousden, Karen H. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (10) :1618-1621
[10]
UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination [J].
Hosoda, M ;
Ozaki, T ;
Miyazaki, K ;
Hayashi, S ;
Furuya, K ;
Watanabe, K ;
Nakagawa, T ;
Hanamoto, T ;
Todo, S ;
Nakagawara, A .
ONCOGENE, 2005, 24 (48) :7156-7169